| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,848 |
5,667 |
$269K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,661 |
1,594 |
$112K |
| 87428 |
|
843 |
836 |
$48K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
483 |
476 |
$15K |
| T1015 |
Clinic visit/encounter, all-inclusive |
94 |
90 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,113 |
560 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,266 |
1,251 |
$12K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
141 |
138 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
198 |
174 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
65 |
62 |
$5K |
| 81025 |
|
522 |
505 |
$3K |
| 81002 |
|
471 |
455 |
$953.35 |
| 87210 |
|
270 |
262 |
$919.48 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
49 |
46 |
$675.64 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
30 |
28 |
$563.04 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
32 |
29 |
$451.34 |
| 69209 |
|
12 |
12 |
$110.14 |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
14 |
12 |
$75.00 |
| 82962 |
|
13 |
13 |
$25.24 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
12 |
12 |
$20.80 |